BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8378851)

  • 1. [Nephropathy-related disorders of physical and sexual development in girls: experience with successful stimulation by zinc, parlodel and norcolut].
    Kukhtevich AV; Ermolenko VM; Kuznetsova AI; Gitel' EP; Bunatian AF; Smirnova GA; Adnoral SA
    Ter Arkh; 1993; 65(6):54-8. PubMed ID: 8378851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis].
    Kukhtevich AV; Ermolenko VM; Dedov II; Gitel' EP; Buniatian AF; Smirnova GA
    Ter Arkh; 1992; 64(11):66-70. PubMed ID: 1293848
    [No Abstract]   [Full Text] [Related]  

  • 3. [Zinc and parlodel: the treatment potentials for retardation of growth and sexual development in nephropathies in adolescents].
    Kukhtevich AV; Ermolenko VM; Bunatian AF; Gitel' EP; Smirnova GA
    Ter Arkh; 1989; 61(10):106-12. PubMed ID: 2609255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sexual dysfunction and zinc in renal insufficiency].
    del Río Vásquez A; Rico Lenza H
    Med Clin (Barc); 1981 Jul; 77(3):130-4. PubMed ID: 7024662
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uremic hypogonadism syndrome and the possibilities of its treatment].
    Tanchev S; Maleeva A; Visheva N
    Akush Ginekol (Sofiia); 1988; 27(1):59-64. PubMed ID: 3369661
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parlodel in the treatment of hypogonadism in patients with kidney diseases].
    Ermolenko VM; Kukhtevich AV; Dedov II
    Vestn Akad Med Nauk SSSR; 1985; (11):55-60. PubMed ID: 4090655
    [No Abstract]   [Full Text] [Related]  

  • 7. [Zinc in the treatment of hypogonadism in patients with renal pathology].
    Kukhtevich AV; Ermolenko VM; Bunatian AF; Gitel' EP; Nosova AA
    Ter Arkh; 1988; 60(6):79-82. PubMed ID: 3206378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of uremic hypogonadism with parlodel].
    Kukhtevich AV; Ermolenko VM; Dedov II; Mel'nichenko GA; Gitel' EP
    Ter Arkh; 1985; 57(12):39-41. PubMed ID: 4089767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parlodel treatment of hypogonadism in patients with uremia and after kidney transplantation].
    Ermolenko VM; Kukhtevich AV; Dedov II; Bunatian AF; Obydena EA
    Urol Nefrol (Mosk); 1985; (3):58-62. PubMed ID: 3892830
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of recombinant human growth hormone (rhGH) in pubertal patients with CRI/dialysis/post-transplant: Dutch data. Dutch Study Group on Growth in Children with Chronic Renal Disease.
    Hokken-Koelega AC; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED
    Br J Clin Pract Suppl; 1996 Aug; 85():5-6. PubMed ID: 8995017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc supplementation in chronic renal failure.
    Eggert JV; Siegler RL; Edomkesmalee E
    Int J Pediatr Nephrol; 1982 Mar; 3(1):21-4. PubMed ID: 7107115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone (rhGH) is effective in pubertal patients.
    Hokken-Koelega AC
    Br J Clin Pract Suppl; 1996 Aug; 85():12-3. PubMed ID: 8995020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of zinc and parlodel for treatment of physical and sexual development retardation in kidney diseases and rheumatoid arthritis].
    Kukhtevich AV; Ermolenko VM; Adnoral SA; Daminov MA; Shakhbazian IE; Sushkova NI; Smirnova GA; Obydena EA
    Pediatriia; 1991; (4):66-70. PubMed ID: 1712447
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic renal insufficiency in children].
    Loirat C
    Rev Prat; 2001 Feb; 51(4):410-6. PubMed ID: 11355606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the response to rhGH in peritoneal dialysis patients less effective than in patients with chronic renal insufficiency.
    Perfumo F; Verrina E; Edefonti A; Trivelli A; Canepa A; Gusmano R
    Br J Clin Pract Suppl; 1996 Aug; 85():18-20. PubMed ID: 8995022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia.
    Frisk P; Arvidson J; Gustafsson J; Lönnerholm G
    Bone Marrow Transplant; 2004 Jan; 33(2):205-10. PubMed ID: 14628079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment in children before and after renal transplantation.
    Hokken-Koelega AC
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():359-64. PubMed ID: 8887181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of chronic renal failure during 35 years at the Rijeka Clinical Hospital Center].
    Orlić L; Matić-Glazar D; Vlahović A; Zivcić-Cosić S; Maleta I; Martinović BS; Racki S; Madzar Z
    Acta Med Croatica; 2004; 58(1):73-7. PubMed ID: 15125398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.